Magnetothermal Stimulation

Neurodegenerative disorders such as Alzheimer's and Parkinson's are characterized by signal irregularities in neuron cells. While deep brain stimulation (DBS) is a conventional method for treating Parkinson's, it involves surgically implanting an electrode for continuous deep brain stimulation, which may have fatal impacts.

In response to these concerns, scientists have introduced a minimally invasive treatment called "Magnetothermal Neuromodulation." This innovative technique utilizes an alternating magnetic field (AMF) to excite injected transducers, specifically magnetic nanoparticles (MNP).

Our patented approach takes a noninvasive route to treat neurodegenerative disorders. It involves identifying characteristics that indicate the physical attributes of the central nervous system, including parameters to mitigate adverse impacts of magnetothermal stimulation treatments. As part of the treatment, we apply a magnetic field to the brain, utilizing the identified characteristics for thermal stimulation of neuron cells within the brain. Our technique aims to provide an effective and safer alternative for treating neurodegenerative disorders without the need for invasive procedures.